N
Neda Slade
Researcher at Stony Brook University
Publications - 47
Citations - 2333
Neda Slade is an academic researcher from Stony Brook University. The author has contributed to research in topics: Carcinogenesis & Cancer. The author has an hindex of 15, co-authored 45 publications receiving 2149 citations. Previous affiliations of Neda Slade include University of Zagreb.
Papers
More filters
Journal ArticleDOI
Aristolochic acid and the etiology of endemic (Balkan) nephropathy
Arthur P. Grollman,Shinya Shibutani,Masaaki Moriya,Frederick W. Miller,Lin Wu,Ute M. Moll,Naomi Suzuki,Andrea Fernandes,Thomas A. Rosenquist,Zvonimir Medverec,Krunoslav Jakovina,Branko Brdar,Neda Slade,Robert J. Turesky,Goodenough Angela,Robert Rieger,Mato Vukelić,Bojan Jelaković +17 more
TL;DR: The experiments test the hypothesis that chronic dietary poisoning by aristolochic acid is responsible for EN and its associated urothelial cancer and conclude that dietary exposure to AA is a significant risk factor for ENand its attendant transitional cell cancer.
Journal Article
p63 and p73: roles in development and tumor formation.
Ute M. Moll,Neda Slade +1 more
TL;DR: The tumor suppressor p53 is critically important in the cellular damage response and is the founding member of a family of proteins as discussed by the authors, which regulate cell cycle and apoptosis after DNA damage, and despite a remarkable structural and partly functional similarity among p53, mouse knockout studies revealed an unexpected functional diversity among them.
Journal ArticleDOI
ΔNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors
Alex Zaika,Neda Slade,Susan Erster,Christine Sansome,Troy W. Joseph,Michael L. Pearl,Eva Chalas,Ute M. Moll +7 more
TL;DR: Deregulated expression of ΔNp73 can bestow oncogenic activity upon the TP73 gene by functionally inactivating the suppressor action of p53 and TAp73 via a dominant-negative family network.
Journal ArticleDOI
Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid
Bojan Jelaković,Sandra Karanović,Ivana Vuković-Lela,Frederick W. Miller,Karen L. Edwards,Jovan Nikolic,Karla Tomić,Neda Slade,Branko Brdar,Robert J. Turesky,Želimir Stipančić,Damir Dittrich,Arthur P. Grollman,Kathleen G. Dickman +13 more
TL;DR: Dietary exposure to aristolochic acid is causally related to endemic nephropathy and carcinomas of the upper urinary tract and TP53 mutations in tumor tissues are identified by chip sequencing.
Journal ArticleDOI
Transdominant ΔTAp73 Isoforms Are Frequently Up-regulated in Ovarian Cancer. Evidence for Their Role as Epigenetic p53 Inhibitors in Vivo
Nicole Concin,Kirsten Becker,Neda Slade,Susan Erster,Elizabeth Mueller-Holzner,Hanno Ulmer,Guenter Daxenbichler,Alain G. Zeimet,Robert Zeillinger,Christian Marth,Ute M. Moll +10 more
TL;DR: It is found that the set of NH2-terminal p73 isoforms distinguishes ovarian cancer patients from healthy controls and thus is a molecular marker for this diagnosis, and strongly supports the hypothesis that overexpression of transdominant p 73 isoforms can function as epigenetic inhibitors of p53 in vivo, thereby alleviating selection pressure for p53 mutations in tumors.